Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Transcriptome™ Companion Diagnostic Test

IRVING, Texas, May 3, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company's MI Transcriptome™...

from PR Newswire: http://bit.ly/2PJ2RNg